Baidu
map

再鼎医药新型抗生素——奥玛环素上市申请获NMPA优先审评

2020-05-10 MedSci MedSci原创

5月6号,再鼎医药今日宣布,国家药品监督管理局(NMPA)药品审评中心已经授予其甲苯磺酸奥玛环素(omadacycline)的新药上市申请优先审评资格,用于治疗社区获得性细菌性肺炎 (CABP)及急性

5月6号,再鼎医药今日宣布,国家药品监督管理局(NMPA)药品审评中心已经授予其甲苯磺酸奥玛环素(omadacycline,也称为奥马环素)的新药上市申请优先审评资格,用于治疗社区获得性细菌性肺炎 (CABP)及急性细菌性皮肤和皮肤结构感染(ABSSSI)。

甲苯磺酸奥玛环素(NUZYRA®)是一种新型四环素,其设计旨在克服四环素耐药性,并具有广谱抗菌活性,包括革兰阳性菌、革兰阴性菌、非典型病原体和多种耐药菌株。奥玛环素是新型9-氨甲基环素类抗生素,是米诺环素的半合成衍生物。其作用机制与四环素类药物(多西环素、米诺环素和四环素)相似,通过与微生物的30S核糖体亚基相结合,抑制蛋白质合成。

NUZYRA于2019年2月在美国上市,作为每日一次的口服和静脉注射抗生素用于治疗CABP和ABSSSI成人患者。中国国家药品监督管理局于2020年2月10日受理甲苯磺酸奥玛环素的新药上市申请,用于治疗CABP和ABSSSI。三项关键性全球研究结果分别显示其在ABSSSI和CABP中疗效非劣于利奈唑胺和莫西沙星,2019年2月其关键研究分别发表于著名的《新英格兰医学杂志》和《柳叶刀》

根据一项入组超过2,000名患者的综合临床研究,2018年10月,美国食品药品监督管理局(FDA)批准了甲苯磺酸奥玛环素(Nuzyra®)针对CABP和ABSSSI的上市申请。国家药监局已将甲苯磺酸奥玛环素纳入了一类新药,未来其将在中国本土进行生产。
 
甲苯磺酸奥玛环素(Nuzyra®)是一种新型四环素,其设计旨在克服四环素耐药性,并具有广谱抗菌活性,包括革兰阳性菌、革兰阴性菌、非典型病原体和多种耐药菌株。Nuzyra是一种现代化的四环素类抗生素,于2019年2月在美国上市,作为每日一次的口服和静脉注射抗生素用于治疗罹患CABP和ABSSSI的成人。
 
目前,Nuzyra正开发用于多种细菌性感染的治疗,除了ABSSSI、CABP之外,还包括尿路感染(UTI)及其他社区获得性细菌性感染。在美国,FDA此前已授予Nuzyra治疗CABP、ABSSSI和UTI的合格传染病产品(QIDP)资格和快速通道地位。根据与美国国防部的一项研究协议,Nuzyra也正被评估治疗引起公共卫生和具有生物防御重要性的传染病病原体,包括鼠疫和炭疽热

亮点一 抗菌谱广,可覆盖ABSSSI和CABP的常见病原菌

对于ABSSSI和CABP最常见的病原菌,如金黄色葡萄球菌,化脓链球菌、肺炎链球菌和流感嗜血杆菌等,奥玛环素均显示出较强的体外抑制活性,与其在国外已获批的适应症一致。

亮点二 对常见的耐药菌株,奥玛环素抑菌作用同样显著

甲氧西林耐药金黄色葡萄球菌对奥玛环素高度敏感。对于中国CABP中最常见病原体之一的肺炎链球菌,无论其是对青霉素耐药,以及对大环内酯类药物耐药,奥玛环素同样具有高度抗菌活性。对产与非产ESBL大肠埃希菌或肺炎克雷伯菌,奥玛环素均表现出非常强的抗菌作用。

亮点三 对于碳青霉烯耐药革兰阴性细菌仍保持活性

再鼎医药创始人、董事长兼首席执行官杜莹博士表示:“此次甲苯磺酸奥玛环素的新药上市申请获得优先审评资格,彰显了国内抗感染领域存在的巨大未满足需求,患者亟需创新的抗生素药物以解决日益严峻的细菌耐药问题。甲苯磺酸奥玛环素抗菌谱广且对耐药菌株具有高度活性,适合中国CABP和ABSSSI患者的治疗。我们将积极配合审评审批部门的工作,让这款药物尽快惠及国内患者。”  

再鼎医药自身免疫及抗感染领域首席医学官Harald Reinhart博士补充道:“CABP是流感、新冠等呼吸道病毒感染后的一种常见继发感染。近期疫情的蔓延让我们再度认识到,像甲苯磺酸奥玛环素这类抗生素存在巨大的临床需求缺口,而市场上少有像甲苯磺酸奥玛环素这样强效、并同时具有静脉输注和口服两种给药方式的抗生素。” 

国家食品药品监督管理总局于2017年12月发布《关于鼓励药品创新实行优先审评审批的意见》,以此为指导,我国设立了优先审评审批制度,以方便药品注册,加快具有临床价值的新药的开发。根据该指导意见,注册部门将优先审核和评估获得优先审评资格的药品,以缩短审评审批时间。

关于再鼎医药

再鼎医药是一家创新型生物制药公司,致力于为中国及全球的肿瘤、自身免疫性及感染性疾病患者提供创新药物。公司经验丰富的团队已与全球领先的生物制药公司建立了战略合作,打造了一系列的候选创新药物,以满足中国医药市场的快速增长和全球范围内未满足的医疗需求。再鼎医药已建立起具有强大药物研发和转化研究能力的内部团队,旨在打造起拥有国际知识产权的候选药物管线。再鼎医药的远景是成为一家全面整合的创新生物制药公司,研发、生产并销售创新产品,为促进全世界人类的健康福祉而努力。

参考资料:

[1] 喜讯!甲苯磺酸奥玛环素新药上市申请获优先审评资格. Retrieved 2020-05-06, from https://mp.weixin.qq.com/s/FUlH1Kvu749Dhv41lxF0cA
 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=881860, encodeId=f824881860cd, content=<a href='/topic/show?id=d98d445642c' target=_blank style='color:#2F92EE;'>#奥玛环素#</a>对很多耐药菌均有抑菌作用,这个牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44564, encryptionId=d98d445642c, topicName=奥玛环素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 01 20:37:42 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676874, encodeId=c91516e6874d6, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58231, encryptionId=63825823146, topicName=新型抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bab27396846, createdName=marongnuan, createdTime=Thu Jun 11 12:17:40 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634775, encodeId=99da1634e754c, content=<a href='/topic/show?id=6da725e314e' target=_blank style='color:#2F92EE;'>#优先审评#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25731, encryptionId=6da725e314e, topicName=优先审评)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4be222283241, createdName=ms5822920152752585, createdTime=Thu Jun 18 20:17:40 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389627, encodeId=f071138962e69, content=<a href='/topic/show?id=226d30e1046' target=_blank style='color:#2F92EE;'>#再鼎医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30710, encryptionId=226d30e1046, topicName=再鼎医药)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5PdY90y5Jib8FnPhCXTR2d9v3K17epNSwB2eb0vmXUldNJl2e72S4unZTAHLAojicdVSialTDFHAxA/132, createdBy=78d82500042, createdName=ms7514935887898259, createdTime=Tue May 12 01:17:40 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410020, encodeId=9d0f1410020c2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue May 12 01:17:40 CST 2020, time=2020-05-12, status=1, ipAttribution=)]
    2020-09-01 lovetcm

    #奥玛环素#对很多耐药菌均有抑菌作用,这个牛

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=881860, encodeId=f824881860cd, content=<a href='/topic/show?id=d98d445642c' target=_blank style='color:#2F92EE;'>#奥玛环素#</a>对很多耐药菌均有抑菌作用,这个牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44564, encryptionId=d98d445642c, topicName=奥玛环素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 01 20:37:42 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676874, encodeId=c91516e6874d6, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58231, encryptionId=63825823146, topicName=新型抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bab27396846, createdName=marongnuan, createdTime=Thu Jun 11 12:17:40 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634775, encodeId=99da1634e754c, content=<a href='/topic/show?id=6da725e314e' target=_blank style='color:#2F92EE;'>#优先审评#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25731, encryptionId=6da725e314e, topicName=优先审评)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4be222283241, createdName=ms5822920152752585, createdTime=Thu Jun 18 20:17:40 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389627, encodeId=f071138962e69, content=<a href='/topic/show?id=226d30e1046' target=_blank style='color:#2F92EE;'>#再鼎医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30710, encryptionId=226d30e1046, topicName=再鼎医药)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5PdY90y5Jib8FnPhCXTR2d9v3K17epNSwB2eb0vmXUldNJl2e72S4unZTAHLAojicdVSialTDFHAxA/132, createdBy=78d82500042, createdName=ms7514935887898259, createdTime=Tue May 12 01:17:40 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410020, encodeId=9d0f1410020c2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue May 12 01:17:40 CST 2020, time=2020-05-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=881860, encodeId=f824881860cd, content=<a href='/topic/show?id=d98d445642c' target=_blank style='color:#2F92EE;'>#奥玛环素#</a>对很多耐药菌均有抑菌作用,这个牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44564, encryptionId=d98d445642c, topicName=奥玛环素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 01 20:37:42 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676874, encodeId=c91516e6874d6, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58231, encryptionId=63825823146, topicName=新型抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bab27396846, createdName=marongnuan, createdTime=Thu Jun 11 12:17:40 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634775, encodeId=99da1634e754c, content=<a href='/topic/show?id=6da725e314e' target=_blank style='color:#2F92EE;'>#优先审评#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25731, encryptionId=6da725e314e, topicName=优先审评)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4be222283241, createdName=ms5822920152752585, createdTime=Thu Jun 18 20:17:40 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389627, encodeId=f071138962e69, content=<a href='/topic/show?id=226d30e1046' target=_blank style='color:#2F92EE;'>#再鼎医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30710, encryptionId=226d30e1046, topicName=再鼎医药)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5PdY90y5Jib8FnPhCXTR2d9v3K17epNSwB2eb0vmXUldNJl2e72S4unZTAHLAojicdVSialTDFHAxA/132, createdBy=78d82500042, createdName=ms7514935887898259, createdTime=Tue May 12 01:17:40 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410020, encodeId=9d0f1410020c2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue May 12 01:17:40 CST 2020, time=2020-05-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=881860, encodeId=f824881860cd, content=<a href='/topic/show?id=d98d445642c' target=_blank style='color:#2F92EE;'>#奥玛环素#</a>对很多耐药菌均有抑菌作用,这个牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44564, encryptionId=d98d445642c, topicName=奥玛环素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 01 20:37:42 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676874, encodeId=c91516e6874d6, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58231, encryptionId=63825823146, topicName=新型抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bab27396846, createdName=marongnuan, createdTime=Thu Jun 11 12:17:40 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634775, encodeId=99da1634e754c, content=<a href='/topic/show?id=6da725e314e' target=_blank style='color:#2F92EE;'>#优先审评#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25731, encryptionId=6da725e314e, topicName=优先审评)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4be222283241, createdName=ms5822920152752585, createdTime=Thu Jun 18 20:17:40 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389627, encodeId=f071138962e69, content=<a href='/topic/show?id=226d30e1046' target=_blank style='color:#2F92EE;'>#再鼎医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30710, encryptionId=226d30e1046, topicName=再鼎医药)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5PdY90y5Jib8FnPhCXTR2d9v3K17epNSwB2eb0vmXUldNJl2e72S4unZTAHLAojicdVSialTDFHAxA/132, createdBy=78d82500042, createdName=ms7514935887898259, createdTime=Tue May 12 01:17:40 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410020, encodeId=9d0f1410020c2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue May 12 01:17:40 CST 2020, time=2020-05-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=881860, encodeId=f824881860cd, content=<a href='/topic/show?id=d98d445642c' target=_blank style='color:#2F92EE;'>#奥玛环素#</a>对很多耐药菌均有抑菌作用,这个牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44564, encryptionId=d98d445642c, topicName=奥玛环素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 01 20:37:42 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676874, encodeId=c91516e6874d6, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58231, encryptionId=63825823146, topicName=新型抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bab27396846, createdName=marongnuan, createdTime=Thu Jun 11 12:17:40 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634775, encodeId=99da1634e754c, content=<a href='/topic/show?id=6da725e314e' target=_blank style='color:#2F92EE;'>#优先审评#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25731, encryptionId=6da725e314e, topicName=优先审评)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4be222283241, createdName=ms5822920152752585, createdTime=Thu Jun 18 20:17:40 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389627, encodeId=f071138962e69, content=<a href='/topic/show?id=226d30e1046' target=_blank style='color:#2F92EE;'>#再鼎医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30710, encryptionId=226d30e1046, topicName=再鼎医药)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5PdY90y5Jib8FnPhCXTR2d9v3K17epNSwB2eb0vmXUldNJl2e72S4unZTAHLAojicdVSialTDFHAxA/132, createdBy=78d82500042, createdName=ms7514935887898259, createdTime=Tue May 12 01:17:40 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410020, encodeId=9d0f1410020c2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue May 12 01:17:40 CST 2020, time=2020-05-12, status=1, ipAttribution=)]
    2020-05-12 cathymary

相关资讯

第27批拟被纳入优先审评药品名单出炉 26药品入选

CDE官网公示了第二十七批拟纳入优先审评程序药品注册申请名单,其中,12药品为新药上市,9药品为新药临床,其余5药品为仿制药上市申请。

8款药品注册申请拟纳入优先审评

2019年3月29日,药审中心公示的拟优先审评的药品品种新增“盐酸安非他酮缓释片”等,公示期间如有异议,可在药审中心网站“信息公开-->优先审评公示-->拟优先审评品种公示”栏目下提出异议。

银屑病治疗药物本维莫德乳膏获批上市

5月31日,国家药监局发布公告称,近期,国家药品监督管理局通过优先审评审批程序批准1类创新药本维莫德乳膏上市,用于局部治疗成人轻至中度稳定性寻常型银屑病。

新增15个品种拟被CDE纳入优先审评程序

8月19日至22日,CDE网站拟优先审评公示栏新增15个品种。拟同意纳入优先审评的理由分别是:注射用复方维生素(13)为仿制药上市;小儿钠钾镁钙葡萄糖注射液、小儿等渗电解质注射液为儿童药;曲美替尼片、达拉非尼胶囊、HSK3486乳状注射液、西妥昔单抗注射液、帕博利珠单抗注射液为具有明显治疗优势药品;阿卡波糖片则为符合117公告品种、申请人主动撤回的优先条件。

快来看!这些药品和疫苗的注册申请拟纳入优先审评程序啦!

国家食品药品监督管理总局药品审评中心2018年4月23日发布“拟纳入优先审评程序药品注册申请的公示(第二十八批)”

抗疟疾新药获FDA优先审评资格

近日,60 Degrees Pharmaceuticals(60P)宣布,美国FDA授予其预防成人疟疾药物Tafenoquine (TQ)优先审评资格。2018年1月,该药物获得FDA的快速通道资格。

拓展阅读

再鼎医药重症肌无力新药皮下注射剂型艾加莫德α注射液国内申报上市

7月8日,CDE官网显示,再鼎医药艾加莫德α注射液(皮下注射,efgartigimod PH20 SC)上市申请获受理,推测适应症为全身型重症肌无力。

再鼎1.9亿美元引进再生元CD20xCD3双抗进展,已获批临床

亿欧大健康9月8日消息,今日CDE官网公示,再鼎医药申报的REGN1979注射液获批5项临床默示许可,适应症为“既往全身治疗后复发或难治的B细胞非霍奇金淋巴瘤(B-NHL)患者&rdquo

再生元与再鼎医药合作开发REGN1979(CD20xCD3双特异性抗体),治疗非霍奇金淋巴瘤

REGN1979是利用Regeneron双特异性抗体平台开发的新型双特异性单克隆抗体,旨在通过将细胞毒性T细胞(与CD3结合)与淋巴瘤细胞(与CD20结合)连接并激活来杀死肿瘤。

肿瘤电场治疗在港上市,胶质母细胞瘤迎十年来突破性疗法

今日(2月28日),再鼎医药宣布,首款肿瘤电场治疗产品Optune®在香港正式上市。肿瘤电场治疗是一种利用特定电场频率干扰细胞分裂,抑制肿瘤增长并使受电场影响的癌细胞死亡的治疗方案。Optune®作为全球首个且唯一经美国FDA批准的肿瘤电场治疗产品,已在美国、欧洲、日本及其他多个国家及地区获批用于胶质母细胞瘤的治疗,同时其他多项应用于实体肿瘤适应症的临床试验也在同步进行。肿瘤电场治疗为胶质母细胞瘤

喜讯!陈列平教授加入再鼎医药科学顾问委员会

再鼎医药今日宣布,聘请肿瘤免疫疗法先驱陈列平教授为公司科学顾问委员会成员,为再鼎医药不断发展的抗肿瘤新药自主研发方向和项目,特别是在肿瘤免疫方面,提供建议及指导。 再鼎医药董事长兼首席执行官杜莹博士表示: “我们非常荣幸像陈列平教授这样的肿瘤免疫学家可以加入再鼎医药的科学顾问委员会。作为免疫肿瘤研究的先驱,陈教授在肿瘤免疫方面的研究尤其是PD-1/PD-L1抗体方面的发现为肿瘤

再鼎医药香港上市肿瘤电场治疗产品Optune

再鼎医药(纳斯达克股票代码:ZLAB)今天宣布,用于多形性胶质母细胞瘤(GBM)的肿瘤治疗电场Optune已经正式登陆香港并惠及首位患者。再鼎医药今天宣布,用于多形性胶质母细胞瘤(GBM)的肿瘤治疗电场Optune已经正式登陆香港并惠及首位患者。香港是继美国,欧洲和日本之后第四个上市该治疗方案的市场。Optune也是继治疗卵巢癌的PARP抑制剂则乐(尼拉帕利)后再鼎医药上市的第二款产品。作为一种全

Baidu
map
Baidu
map
Baidu
map